dc.contributor.author | Demirel, A. | |
dc.contributor.author | Ozaras, R. | |
dc.date.accessioned | 2020-12-02T18:00:14Z | |
dc.date.available | 2020-12-02T18:00:14Z | |
dc.date.issued | 2018 | |
dc.identifier.isbn | 9783319934495; 9783319934488 | |
dc.identifier.uri | https://doi.org/10.1007/978-3-319-93449-5_9 | |
dc.identifier.uri | http://hdl.handle.net/11446/3574 | |
dc.description.abstract | [No abstract available] | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer International Publishing | en_US |
dc.identifier.doi | 10.1007/978-3-319-93449-5_9 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Future drugs in the treatment of HBV | en_US |
dc.type | bookPart | en_US |
dc.relation.journal | Viral Hepatitis: Chronic Hepatitis B | en_US |
dc.department | DBÜ | en_US |
dc.identifier.startpage | 105 | en_US |
dc.identifier.endpage | 117 | en_US |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.department-temp | Demirel, A., Department of Infectious Diseases and Clinical Microbiology, Florence Nightingale Hospital, Bilim University, Istanbul, Turkey; Ozaras, R., Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey | en_US |